Kurnat-Thoma Emma L, Pangilinan Faith, Matteini Amy M, Wong Bob, Pepper Ginette A, Stabler Sally P, Guralnik Jack M, Brody Lawrence C
Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA National Institute of Nursing Research, National Institutes of Health, Bethesda, MD, USA University of Utah, College of Nursing, Salt Lake City, UT, USA.
Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Biol Res Nurs. 2015 Jul;17(4):444-54. doi: 10.1177/1099800415569506. Epub 2015 Feb 5.
Cobalamin (vitamin B12) deficiency is a subtle progressive clinical disorder, affecting nearly 1 in 5 individuals > 60 years old. This deficiency is produced by age-related decreases in nutrient absorption, medications that interfere with vitamin B12 absorption, and other comorbidities. Clinical heterogeneity confounds symptom detection for elderly adults, as deficiency sequelae range from mild fatigue and weakness to debilitating megaloblastic anemia and permanent neuropathic injury. A better understanding of genetic factors that contribute to cobalamin deficiency in the elderly would allow for targeted nursing care and preventive interventions. We tested for associations of common variants in genes involved in cobalamin transport and homeostasis with metabolic indicators of cobalamin deficiency (homocysteine and methylmalonic acid) as well as hematologic, neurologic, and functional performance features of cobalamin deficiency in 789 participants of the Women's Health and Aging Studies. Although not significant when corrected for multiple testing, eight single nucleotide polymorphisms (SNPs) in two genes, transcobalamin II (TCN2) and the transcobalamin II-receptor (TCblR), were found to influence several clinical traits of cobalamin deficiency. The three most significant findings were the identified associations involving missense coding SNPs, namely, TCblR G220R (rs2336573) with serum cobalamin, TCN2 S348F (rs9621049) with homocysteine, and TCN2 P259R (rs1801198) with red blood cell mean corpuscular volume. These SNPs may modify the phenotype in older adults who are more likely to develop symptoms of vitamin B12 malabsorption.
钴胺素(维生素B12)缺乏是一种隐匿性进行性临床疾病,在60岁以上的人群中,近五分之一的人受其影响。这种缺乏是由与年龄相关的营养吸收减少、干扰维生素B12吸收的药物以及其他合并症引起的。临床异质性使老年人的症状检测变得复杂,因为缺乏症的后遗症范围从轻度疲劳和虚弱到使人衰弱的巨幼细胞贫血和永久性神经病变损伤。更好地了解导致老年人钴胺素缺乏的遗传因素,将有助于进行有针对性的护理和预防干预。我们在789名妇女健康与衰老研究参与者中,测试了参与钴胺素转运和内稳态的基因中的常见变异与钴胺素缺乏的代谢指标(同型半胱氨酸和甲基丙二酸)以及钴胺素缺乏的血液学、神经学和功能表现特征之间的关联。尽管在进行多重检验校正后不显著,但在两个基因,即转钴胺素II(TCN2)和转钴胺素II受体(TCblR)中发现的八个单核苷酸多态性(SNP)影响了钴胺素缺乏的几个临床特征。三个最显著的发现是所确定的涉及错义编码SNP的关联,即TCblR G220R(rs2336573)与血清钴胺素、TCN2 S348F(rs9621049)与同型半胱氨酸以及TCN2 P259R(rs1801198)与红细胞平均体积之间的关联。这些SNP可能会改变更易出现维生素B12吸收不良症状的老年人的表型。